GlaxoSmithKline has suffered a 26 per cent fall in its first-quarter operating profit, and is to sell off its consumer soft drink brands Ribena and Lucozade. This could raise a billion pounds for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback